Search
Searching Content indexed under Patent by Finnegan, Henderson, Farabow, Garrett & Dunner, LLP ordered by Published Date Descending.
Links to Result pages
 
1 2 3 4 5 6 7 8 9 10 11 . . .  
>>Next
 
Title
Country
Organisation
Author
Date
1
Federal Circuit PTAB Appeal Statistics – October 2016
Through October 1, 2016, the Federal Circuit decided 120 PTAB appeals from IPRs and CBMs. The Federal Circuit affirmed the PTAB on every issue in 95 (79.17%) of the cases, and reversed or vacated the PTAB on every issue in 9 (7.50%) of the cases.
United States
17 Sep 2019
2
Prosecution Pointer 191
DOCX is part of the USPTO's eMod efforts to expand the filing formats used for filing patent applications.
United States
16 Sep 2019
3
September 2019 - Last Month At The Federal Circuit Podcast Series
Welcome to the Last Month at the Federal Circuit, a look at recent Federal Circuit decisions impacting the intellectual property community.
United States
12 Sep 2019
4
Podcast Series: Last Month At The Federal Circuit - September 2019
Welcome to the Last Month at the Federal Circuit, a look at recent Federal Circuit decisions impacting the intellectual property community.
United States
12 Sep 2019
5
35 U.S.C. § 314(d) Prevents Appeal Of PTAB's Decision To Deny Institution Upon Reconsideration
In BioDelivery Sciences International, Inc. v. Aquestive Therapeutics, Inc., Nos. 19-1643, 19-1644, 19-1645 (Fed. Cir. Aug. 29, 2019), the Federal Circuit granted Aquestive
United States
12 Sep 2019
6
Claim Language "Lofty . . . Batting" Found Not Invalid On Indefiniteness And Anticipation Grounds
In Guangdong Alison Hi-Tech Co. v. International Trade Commission, No. 2018-2042 (Fed. Cir. Aug. 27, 2019), the Federal Circuit affirmed the ITC's findings that the claims of U.S.
United States
12 Sep 2019
7
"Wherein" Clauses May Be Limiting
In Allergan Sales, LLC v. Sandoz, Inc., No. 2018-2207 (Fed. Cir. Aug. 29, 2019), the Federal Circuit held that the "wherein" clauses in Allergan's method-of-treatment claims are limiting.
United States
12 Sep 2019
8
IPR Estoppel Does Not Apply To Physical Products Described In Printed Publications Available During IPR
In Polaris Indus., Inc. v. Arctic Cat Inc., the court (District of Minnesota) held that defendant was not estopped under § 315(e)(2) from asserting three invalidity combinations involving physical
United States
11 Sep 2019
9
Overcoming Obviousness Rejections By Attacking The Prima Facie Case
This practice note teaches patent prosecutors how to overcome a patent examiner's obviousness rejection by attacking the examiner's prima facie case.
United States
11 Sep 2019
10
Ridesharing Dispute Exposes Differences Between Strong And Weak Patents
In the late 1990's, Stephen Dickerson, then a Professor at Georgia Tech, developed what he claims is the basis for all ridesharing technology
United States
9 Sep 2019
11
Prosecution Pointer 190
The expanded Collaborative Search Pilot (CSP), running from November 1, 2017 through October 31, 2020,
United States
6 Sep 2019
12
"Substantially Equivalent" Method Of Obtaining Dissolution Profile Meets Written Description Requirement
In Nalpropion Pharmaceuticals v. Actavis Laboratories FL, Inc., No. 2018-1221, the Court addressed whether a particular claimed dissolution profile had the requisite written description support.
United States
5 Sep 2019
13
Recent Developments In Patent Law: Non-Obviousness Of Pharmaceutical Formulations
The development of pharmaceutical products is often expensive and unpredictable. Researchers investing the time and resources to develop a novel and non-obvious advancement over the art are rewarded with patent protection
United States
4 Sep 2019
14
Practical Considerations For America Invents Act Trial Strategies
Since their inception in 2012, more than 9,600 AIA trials have been filed. The Federal Circuit has decided over 420 appeals stemming
United States
4 Sep 2019
15
Practical Considerations For American Invents Act Trial Strategies
Since their inception in 2012, more than 9,600 AIA trials have been filed. The Federal Circuit has decided over 420 appeals stemming from Patent Trial and Appeal Board (PTAB)
United States
2 Sep 2019
16
Spotlight On Upcoming Oral Arguments – September 2019
Chrimar sued ALE alleging that ALE's products infringed four of Chrimar's patents. The district court found that the patents were valid and awarded damages and ongoing royalties to Chrimar.
United States
2 Sep 2019
17
Prosecution Pointer 189
Design applications requesting expedited examination and complying with the requirements of 37 CFR 1.155 are examined with priority
United States
30 Aug 2019
18
Claim Amendment To Avoid Unrelated Prior Art Protein Is Unrelated To Codon-Randomized Versions Of Protein-At-Issue And Do Not Trigger Prosecution History Estoppel Under The Tangential Exception
In Ajinomoto Co. v. Int'l Trade Comm'n, Nos. 2018-1590, 2018-1629 (Fed. Cir. Aug. 6, 2019), the Federal Circuit applied the tangential relation exception
United States
29 Aug 2019
19
A Simple Guide To Priority In The UK
Priority is a core concept of patent law as the novelty and obviousness of an invention is judged as of the priority date.
UK
29 Aug 2019
20
Federal Circuit Required Resolution Of Claim Construction Dispute Before Ruling On Patent Eligibility At Rule 12(c) Stage
In MyMail, Ltd., v. ooVoo, LLC IAC Search & Media, Inc., Nos. 2018-1758, 2018-1759 (Fed. Cir. Aug. 16, 2019), the Court vacated and remanded a determination regarding patent eligibility
United States
29 Aug 2019
Links to Result pages
 
1 2 3 4 5 6 7 8 9 10 11 . . .  
>>Next